Long-Lasting Effect of Dexrazoxane Against Anthracycline Cardiotoxicity in Rats
- 2 July 1996
- journal article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 24 (4), 398-402
- https://doi.org/10.1177/019262339602400402
Abstract
The long-lasting protective effect of dexrazoxane (ADR-529) against doxorubicin- and epirubicin-induced cardiotoxicity was evaluated in the multiple-dose 35-wk rat model. Groups of 36 male Sprague-Dawley rats were given ADR-529 30 min before administration of cardiotoxic doses of doxorubicin (1 mg/kg/wk) or epirubicin (1.13 mg/kg/wk). The compounds were intravenously injected once weekly for 7 consecutive wk at ADR-529: anthracycline ratios ranging from 5:1 to 20:1. These ratios covered the entire chemotherapeutic range in humans and allowed studying the chronic progressive cardiomyopathy in our rat model. Animals were observed for up to 35 wk to follow the time course of the well-characterized cardiomyopathy, which was evaluated through the well-established qualitative/quantitative morphological grading. It was clearly demonstrated in this rat model that ADR-529, at the ratios administered, provided ample cardioprotection for a duration of 35 wk, which corresponds to 25 yr of equivalent human time.Keywords
This publication has 13 references indexed in Scilit:
- Disruption of Mitochondrial Calcium Homeostasis Following Chronic Doxorubicin AdministrationToxicology and Applied Pharmacology, 1994
- Effects of Adriamycin on Ionic Currents in Single Cardiac Myocytes of the RabbitJournal of Molecular and Cellular Cardiology, 1994
- Pharmacodynamics of the Hydrolysis-Activation of the Cardioprotective Agent (+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propaneJournal of Pharmaceutical Sciences, 1994
- Evaluation of 4′-Iodo-4′-Deoxydoxorubicin-Induced Cardiotoxicity in Two Experimental Rat ModelsToxicologic Pathology, 1994
- EpirubicinDrugs, 1993
- Mitochondrial regulation of superoxide by Ca2+: An alternate mechanism for the cardiotoxicity of doxorubicinToxicology and Applied Pharmacology, 1991
- Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathyCancer Treatment Reviews, 1990
- Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the ratToxicology and Applied Pharmacology, 1990
- Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complexBiochemical Pharmacology, 1984
- Multiple Comparisons Using Rank SumsTechnometrics, 1964